PropThink: Hope For LLY's Alzheimer's Drug Remains Alive; Stock Will Reflect Optimism
Eli Lilly & Co. announced this morning that its potential treatment to slow the onset of Alzheimer's Disease, solanezumab, showed favorable effects in its Phase III clinical program.
Join the discussion below, or Read more at PR-inside.com.
Mermaid Beach, Australia
#1 Aug 25, 2012
I use an Eli Lilly drug to successfully control Alzheimers/Dementia.....I have notified them, my Doctor has spoken to them,but we never hear or see anything about this from the company, in any public statements......I had a website established to tell the world of my good fortune, because it seems no one else was going to..if I had not gone public,the world would still not know, and I believe it should, everyone should know what has happened to me.....www.adbi.com.au...
I sincerely hope this find of mine can/will help others afflicted with this disease, both family and friends. Tony Hogben,Bribie Island, Queensland, Australia.
Add your comments below
Copyright © 2017 Topix LLC